Day 2, July 6, 12:30 p.m., Session C:
Novel biochemical approaches for next generations of antibiotics
Franziska Faber studied biology at the Martin-Luther University (Halle/Saale, Germany). Her doctoral work at the Robert Koch Institute (Wernigerode, Germany) introduced her to the field of enteric bacterial infections. In 2011, she started her postdoctoral work in the lab of Andreas Bäumler at the University of California, Davis (USA). Here, she studied the mechanisms by which antibiotic treatment lowers “colonization resistance” against the enteric pathogen Salmonella enterica. More specifically, she explored how inflammation-associated changes in intestinal nutrients contribute to intestinal colonization of S. enterica. In 2018, she joined the Center for Infectious Disease Research (ZINF) in Würzburg as a Young Investigator to study the previously unexplored RNA biology of the intestinal pathogen Clostridioides difficile. Since 2021, she is a Junior Professor and leads a research group at the Helmholtz Institute for RNA-based Infection Research in Würzburg.
Copyright © 2022 BioM Biotech Cluster Development GmbH
Alle Rechte vorbehalten